These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25814953)

  • 21. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense.
    Graf FE; Ludin P; Arquint C; Schmidt RS; Schaub N; Kunz Renggli C; Munday JC; Krezdorn J; Baker N; Horn D; Balmer O; Caccone A; de Koning HP; Mäser P
    Cell Mol Life Sci; 2016 Sep; 73(17):3387-400. PubMed ID: 26973180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
    Witola WH; Inoue N; Ohashi K; Onuma M
    Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
    Scott AG; Tait A; Turner CM
    Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ionophores CCCP and Gramicidin but Not Nigericin Inhibit
    Petersen LM; Beitz E
    Cells; 2020 Oct; 9(10):. PubMed ID: 33096791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update on African Trypanocide Pharmaceutics and Resistance.
    Kasozi KI; MacLeod ET; Ntulume I; Welburn SC
    Front Vet Sci; 2022; 9():828111. PubMed ID: 35356785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter.
    de Koning HP; Jarvis SM
    Acta Trop; 2001 Dec; 80(3):245-50. PubMed ID: 11700182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melarsoprol Resistance in African Trypanosomiasis.
    Fairlamb AH; Horn D
    Trends Parasitol; 2018 Jun; 34(6):481-492. PubMed ID: 29705579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.
    Suswam EA; Taylor DW; Ross CA; Martin RJ
    Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes.
    de Koning HP; Anderson LF; Stewart M; Burchmore RJ; Wallace LJ; Barrett MP
    Antimicrob Agents Chemother; 2004 May; 48(5):1515-9. PubMed ID: 15105099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal.
    Kazibwe AJ; Nerima B; de Koning HP; Mäser P; Barrett MP; Matovu E
    PLoS Negl Trop Dis; 2009 Sep; 3(9):e523. PubMed ID: 19787038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species.
    Changtam C; de Koning HP; Ibrahim H; Sajid MS; Gould MK; Suksamrarn A
    Eur J Med Chem; 2010 Mar; 45(3):941-56. PubMed ID: 20004045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of pentamidine-resistant Trypanosoma brucei brucei.
    Berger BJ; Carter NS; Fairlamb AH
    Mol Biochem Parasitol; 1995 Feb; 69(2):289-98. PubMed ID: 7770092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance.
    Bernhard SC; Nerima B; Mäser P; Brun R
    Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein.
    Sanderson L; Dogruel M; Rodgers J; De Koning HP; Thomas SA
    J Pharmacol Exp Ther; 2009 Jun; 329(3):967-77. PubMed ID: 19261919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aquaglyceroporin-null trypanosomes display glycerol transport defects and respiratory-inhibitor sensitivity.
    Jeacock L; Baker N; Wiedemar N; Mäser P; Horn D
    PLoS Pathog; 2017 Mar; 13(3):e1006307. PubMed ID: 28358927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Review and Meta-Analysis on Human African Trypanocide Resistance.
    Kasozi KI; MacLeod ET; Welburn SC
    Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance.
    Lanteri CA; Stewart ML; Brock JM; Alibu VP; Meshnick SR; Tidwell RR; Barrett MP
    Mol Pharmacol; 2006 Nov; 70(5):1585-92. PubMed ID: 16912218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.